Filing Details

Accession Number:
0001104659-17-052251
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-16 16:08:32
Reporting Period:
2017-08-14
Filing Date:
2017-08-16
Accepted Time:
2017-08-16 16:08:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1556263 Syros Pharmaceuticals Inc. SYRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490283 A Richard Young C/O Syros Pharmaceuticals, Inc.
620 Memorial Drive, Suite 300
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-14 3,282 $22.00 420,101 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.